These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32684984)

  • 1. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Diabetol Metab Syndr; 2020; 12():54. PubMed ID: 32684984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62.
    Takata T; Sakasai-Sakai A; Takeuchi M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.
    Takeuchi M
    Diabetol Metab Syndr; 2020 Nov; 12(1):105. PubMed ID: 33292465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of an Interorgan Network Mediated by Toxic Advanced Glycation End-Products in a Rat Model.
    Inoue S; Takata T; Nakazawa Y; Nakamura Y; Guo X; Yamada S; Ishigaki Y; Takeuchi M; Miyazawa K
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33383715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.
    Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y; Kikuchi C; Furukawa A; Nagamine K; Hori T; Matsunaga T
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.
    Takeuchi M
    Diagnostics (Basel); 2016 Jun; 6(2):. PubMed ID: 27338481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver.
    Takata T; Sakasai-Sakai A; Takino JI; Takeuchi M
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31315223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Toxic AGEs (TAGE) on Human Health.
    Takeuchi M; Sakasai-Sakai A; Takata T; Takino JI; Koriyama Y
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease.
    Takata T; Sakasai-Sakai A; Ueda T; Takeuchi M
    Sci Rep; 2019 Feb; 9(1):2121. PubMed ID: 30765817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review.
    Sakasai-Sakai A; Takata T; Takino JI; Takeuchi M
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30813302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.
    Takeuchi M; Takino J; Sakasai-Sakai A; Takata T; Ueda T; Tsutsumi M; Hyogo H; Yamagishi S
    World J Hepatol; 2014 Dec; 6(12):880-93. PubMed ID: 25544875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells.
    Nasu R; Furukawa A; Suzuki K; Takeuchi M; Koriyama Y
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite.
    Sakai-Sakasai A; Takeda K; Suzuki H; Takeuchi M
    Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Hepatic Stellate Cell Death by Toxic Advanced Glycation End-Products.
    Takino JI; Sato T; Nagamine K; Sakasai-Sakai A; Takeuchi M; Hori T
    Biol Pharm Bull; 2021; 44(1):112-117. PubMed ID: 33390537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion.
    Takata T; Ueda T; Sakasai-Sakai A; Takeuchi M
    World J Gastroenterol; 2017 Jul; 23(27):4910-4919. PubMed ID: 28785145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH.
    Takeuchi M; Sakasai-Sakai A; Takata T; Ueda T; Takino J; Tsutsumi M; Hyogo H; Yamagishi S
    Med Hypotheses; 2015 May; 84(5):490-3. PubMed ID: 25697114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells.
    Sakasai-Sakai A; Takata T; Takeuchi M
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH.
    Sakasai-Sakai A; Takeda K; Takeuchi M
    Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.